Name |
Website |
Launched time |
Main goals |
CIHR |
http://www.cihr-irsc.gc.ca/ |
2000 |
- Transform health research in Canada by applying next-generation sequencing to more research on targeted priority and under-developed areas such as population health and health services research
- Transform research results into policies, practices, procedures, products and services
|
ENCODE |
http://www.genome.gov/10005107 |
2003 |
- Funded by the National Human Genome Research Institute (NHGRI)
- Build a comprehensive parts list of functional elements in the human genome, including elements that act at the protein and RNA levels, and regulatory elements that control cells and circumstances in which a gene is active.
|
NOE |
www.epigenome-noe.net/ |
2004 |
- Provide clear and visible benefits for the entire epigenetic community and as such supports both members and non-members with conferences, work-shops, training visits and shared resources.
|
EPITRON |
www.epitron.eu |
2005 |
- Define the epigenetic treatment and identify novel drugs of cancer
|
HEROIC |
http://www.heroic-ip.eu/ |
2006 |
- Apply high-throughput sequencing technology to do a genome-wide epigenetic research, making a wider contribution to understanding the primary genetic code of chromatin
|
BLUEPRINT |
http://www.blueprint-epigenome.eu/ |
2007 |
- Develop novel technology for high-throughput epigenome mapping
- Provide reference epigenomes and epigenetic drug target
|
CANCERDIP |
www.cancerdip.eu |
2007 |
- Understand the mechanisms of DNA methylation deregulation in human cancer
- Identify epigenetic markers for clinical application
|
AEPIA |
www.epialliance.org.au |
2008 |
- Facilitate communication between Australasian research groups interested in epigenetic-based questions as well as clinicians, students and members of the public interested in epigenetics
|
Roadmap |
www.roadmapepigenomics.org |
2008 |
- Utilize next-generation sequencing technologies to map DNA methylation, histone modifications, chromatin accessibility, and small RNA transcripts in stem cells and primary ex vivo tissues
- Produce a public resource of human epigenomic data to catalyze basic biology and disease-oriented research.
|
ICGC |
www.icgc.org |
2010 |
- Obtain a comprehensive description of genomic, transcriptomic and epigenomic changes in 50 different tumor types and/or subtypes which are of clinical and societal importance across the globe.
|
